Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 4
1982 1
1988 1
1991 3
1992 1
1995 1
1998 1
1999 2
2000 3
2001 1
2002 3
2003 1
2004 1
2005 3
2006 6
2007 7
2008 4
2009 6
2010 10
2011 10
2012 11
2013 7
2014 21
2015 28
2016 32
2017 26
2018 31
2019 34
2020 23
2021 39
2022 38
2023 30
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

355 results

Results by year

Filters applied: . Clear all
Page 1
Music improves social communication and auditory-motor connectivity in children with autism.
Sharda M, Tuerk C, Chowdhury R, Jamey K, Foster N, Custo-Blanch M, Tan M, Nadig A, Hyde K. Sharda M, et al. Transl Psychiatry. 2018 Oct 23;8(1):231. doi: 10.1038/s41398-018-0287-3. Transl Psychiatry. 2018. PMID: 30352997 Free PMC article. Clinical Trial.
Post-intervention brain connectivity was lower between auditory and visual regions in the music compared to the non-music groups, known to be over-connected in autism (z = 4.01, P < .00001). Post-intervention brain connectivity in the music group was relat …
Post-intervention brain connectivity was lower between auditory and visual regions in the music compared to the non-music grou …
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Harter P, Mouret-Reynier MA, Pignata S, Cropet C, González-Martín A, Bogner G, Fujiwara K, Vergote I, Colombo N, Nøttrup TJ, Floquet A, El-Balat A, Scambia G, Guerra Alia EM, Fabbro M, Schmalfeldt B, Hardy-Bessard AC, Runnebaum I, Pujade-Lauraine E, Ray-Coquard I. Harter P, et al. Gynecol Oncol. 2022 Feb;164(2):254-264. doi: 10.1016/j.ygyno.2021.12.016. Epub 2021 Dec 22. Gynecol Oncol. 2022. PMID: 34952708 Free article. Clinical Trial.
RESULTS: Of 806 randomized patients, 74% were higher risk and 26% were lower risk. After a median 22.9 months of follow-up, PFS favored olaparib plus bevacizumab versus placebo plus bevacizumab in higher-risk patients (hazard ratio [HR] 0.60; 95% confidence interval [CI] 0 …
RESULTS: Of 806 randomized patients, 74% were higher risk and 26% were lower risk. After a median 22.9 months of follow-up, PFS favor …
Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
GBD 2019 Healthcare Access and Quality Collaborators. GBD 2019 Healthcare Access and Quality Collaborators. Lancet Glob Health. 2022 Dec;10(12):e1715-e1743. doi: 10.1016/S2214-109X(22)00429-6. Epub 2022 Oct 6. Lancet Glob Health. 2022. PMID: 36209761 Free PMC article.
In contrast, divergence was estimated among the working and post-working groups, driven by slow progress in low-SDI countries. INTERPRETATION: Although major gaps remain across levels of social and economic development, convergence in the young group is an encouraging sign …
In contrast, divergence was estimated among the working and post-working groups, driven by slow progress in low-SDI countries. INTERP …
Neuropathic Ulcer.
Eastman DM, Dreyer MA. Eastman DM, et al. 2022 Nov 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2022 Nov 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32644640 Free Books & Documents.
Peripheral neuropathy usually affects only the extremities and can have multiple sources of causality, most likely being diabetic peripheral neuropathy (see Image. Neuropathic Ulcer). Other sources include shingles (post-herpetic neuralgia), B12 deficiency, alcoholism, tox …
Peripheral neuropathy usually affects only the extremities and can have multiple sources of causality, most likely being diabetic peripheral …
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.
Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Salles G, Kliem V, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S. Trappe RU, et al. J Clin Oncol. 2017 Feb 10;35(5):536-543. doi: 10.1200/JCO.2016.69.3564. Epub 2016 Dec 19. J Clin Oncol. 2017. PMID: 27992268 Clinical Trial.
Purpose The Sequential Treatment of CD20-Positive Posttransplant Lymphoproliferative Disorder (PTLD-1) trial ( ClinicalTrials.gov identifier, NCT01458548) established sequential treatment with four cycles of rituximab followed by four cycles of cyclophosphamide, doxorubicin, vinc …
Purpose The Sequential Treatment of CD20-Positive Posttransplant Lymphoproliferative Disorder (PTLD-1) trial ( ClinicalTrials.gov identifier …
Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation.
Lewis MJ, Reardon LC, Aboulhosn J, Haeffele C, Chen S, Kim Y, Fuller S, Forbess L, Alshawabkeh L, Urey MA, Book WM, Rodriguez F 3rd, Menachem JN, Clark DE, Valente AM, Carazo M, Egbe A, Connolly HM, Krieger EV, Angiulo J, Cedars A, Ko J, Jacobsen RM, Earing MG, Cramer JW, Ermis P, Broda C, Nugaeva N, Ross H, Awerbach JD, Krasuski RA, Rosenbaum M. Lewis MJ, et al. J Am Coll Cardiol. 2023 Jun 6;81(22):2161-2171. doi: 10.1016/j.jacc.2023.03.422. J Am Coll Cardiol. 2023. PMID: 37257951
OBJECTIVES: The purpose of this study was to define survivorship post-HT/CHLT and predictors of post-transplant mortality, including timing of referral, in the adult Fontan population. ...CONCLUSIONS: In our multicenter cohort, post-transplant survival improv …
OBJECTIVES: The purpose of this study was to define survivorship post-HT/CHLT and predictors of post-transplant mortality, inc …
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Lorusso D, Mouret-Reynier MA, Harter P, Cropet C, Caballero C, Wolfrum-Ristau P, Satoh T, Vergote I, Parma G, Nøttrup TJ, Lebreton C, Fasching PA, Pisano C, Manso L, Bourgeois H, Runnebaum I, Zamagni C, Hardy-Bessard AC, Schnelzer A, Fabbro M, Schmalfeldt B, Berton D, Belau A, Lotz JP, Gropp-Meier M, Gladieff L, Lück HJ, Abadie-Lacourtoisie S, Pujade-Lauraine E, Ray-Coquard I. Lorusso D, et al. Int J Gynecol Cancer. 2024 Apr 1;34(4):550-558. doi: 10.1136/ijgc-2023-004995. Int J Gynecol Cancer. 2024. PMID: 38129136 Free PMC article. Clinical Trial.
No benefit was seen in HRD-negative patients regardless of clinical risk. CONCLUSION: This post hoc analysis indicates that in patients with newly diagnosed advanced HRD-positive ovarian cancer, maintenance olaparib plus bevacizumab should not be limited to those considere …
No benefit was seen in HRD-negative patients regardless of clinical risk. CONCLUSION: This post hoc analysis indicates that in patien …
Effect of non-invasive ventilation after extubation in critically ill patients with obesity in France: a multicentre, unblinded, pragmatic randomised clinical trial.
De Jong A, Bignon A, Stephan F, Godet T, Constantin JM, Asehnoune K, Sylvestre A, Sautillet J, Blondonnet R, Ferrandière M, Seguin P, Lasocki S, Rollé A, Fayolle PM, Muller L, Pardo E, Terzi N, Ramin S, Jung B, Abback PS, Guerci P, Sarton B, Rozé H, Dupuis C, Cousson J, Faucher M, Lemiale V, Cholley B, Chanques G, Belafia F, Huguet H, Futier E, Azoulay E, Molinari N, Jaber S; EXTUB-OBESE trial group. De Jong A, et al. Lancet Respir Med. 2023 Jun;11(6):530-539. doi: 10.1016/S2213-2600(22)00529-X. Epub 2023 Jan 21. Lancet Respir Med. 2023. PMID: 36693403 Clinical Trial.
The reintubation within 3 days was analysed by intention to treat and after a post-hoc crossover analysis. This study is registered with ClinicalTrials.gov, number NCT04014920. ...Reintubation within 3 days after extubation was similar in the non-invasive ventilation group …
The reintubation within 3 days was analysed by intention to treat and after a post-hoc crossover analysis. This study is registered w …
Impacted lower third molar relationship with mandibular angle fracture complications.
Beret M, Nicot R, Roland-Billecart T, Ramdane N, Ferri J, Schlund M. Beret M, et al. J Stomatol Oral Maxillofac Surg. 2022 Apr;123(2):149-154. doi: 10.1016/j.jormas.2021.05.004. Epub 2021 May 15. J Stomatol Oral Maxillofac Surg. 2022. PMID: 34000436
The patients were divided in two groups: impacted lower third molar or erupted/absent lower third molar. RESULTS: A total of 68 patients were included, lower third molar was impacted in 36 cases and erupted/absent in 32 cases. 40 complications were recorded i …
The patients were divided in two groups: impacted lower third molar or erupted/absent lower third molar. RESULTS: A total of 6 …
Post-COVID-19 condition: systemic inflammation and low functional exercise capacity.
de Castro GS, Gama LR, Ramos AF, Gatti da Silva G, Teixeira AAS, Cunha-Neto E, de Souza HP, Marie SK, Talib LL, Coelho V, Kalil J, de Araujo AL, Ritto AP, Belon AR, Santos AS, Barrére APN, Sawamura MVY, Lamas CA, Baldi BG, Carvalho CRR, Kulikowski LD, Damiano RF, Imamura M, Rosa Neto JC, Lira FS, Otoch JP, Miguel EC, Battistella L, Forlenza OV, Busatto G, Seelaender M. de Castro GS, et al. Front Nutr. 2024 Mar 14;11:1295026. doi: 10.3389/fnut.2024.1295026. eCollection 2024. Front Nutr. 2024. PMID: 38549752 Free PMC article.
The alterations that drive both the persistent and post-acute disease newly acquired symptoms are not yet fully described. ...SRPF presented lower G-CSF compared to Control (q = 0.014). Female participants in SR showed lower handgrip strength in relation to S …
The alterations that drive both the persistent and post-acute disease newly acquired symptoms are not yet fully described. ...SRPF pr …
355 results